← Evidence map

ArticlePsychopharmacology2021

Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation.

Ramakrishna Nirogi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33550481